SoLá Pelvic Therapy for Chronic Pelvic Pain: A real-world registry
Official title: A Prospective Registry of Vaginal Photobiomodulation for Chronic Pelvic Pain: The VOICE Registry.
Run by SoLa Pelvic Therapy · NCT07799857 · Data updated 2026-11-12
This registry collects real-world data on using transvaginal photobiomodulation with SoLá Pelvic Therapy to help adults with chronic pelvic pain.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 1000 (estimated) |
| Sponsor | SoLa Pelvic Therapy Industry-sponsored |
| Locations | 1 site (Melbourne, Florida) |
| Status | Recruiting |
| Started | April 6, 2026 |
| Main results expected | April 2029 |
| Study ends | April 2030 |
| Registry record updated | September 2, 2026 |
| Trial ID | NCT07799857 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18 years or older who are selected by their clinician to receive transvaginal photobiomodulation with SoLá Pelvic Therapy as part of routine care.
✕Probably not a fit
Patients for whom SoLá Pelvic Therapy is contraindicated or not expected to benefit may be enrolled only if the clinician confirms non-eligibility for the therapy.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The VOICE Registry is a multicenter, prospective, observational program that follows patients receiving SoLá Pelvic Therapy as part of standard care. It aims to gather real-world information on the safety and use of transvaginal photobiomodulation for chronic pelvic pain over 12 months. The study does not assign treatments or prescribe management; decisions on patient selection, frequency of therapy, and concurrent therapies are determined by clinicians. Data collected include device utilization, safety events, and patient-reported outcomes to understand how this therapy is used in routine practice. Participation is based on clinician judgment and patient eligibility (age 18+ and receipt of SPT).
Why it matters
Potential benefit: If successful, the registry could clarify how SoLá Pelvic Therapy is used in real-world settings and identify potential safety signals and patient-reported benefits.
How similar studies have gone: Previous real-world data in similar photobiomodulation approaches have shown potential benefit but evidence remains exploratory in this setting.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18 years or older. * Selected to receive transvaginal photobiomodulation therapy with the SoLá Pelvic Therapy® as part of their standard clinical care. Exclusion Criteria: \- Patients will be excluded from the registry only if the treating healthcare professional determines that SoLá Pelvic Therapy® is not appropriate or contraindicated.
Where it's running
-
Zipper Urogynecology Associates
Melbourne, Florida, United States Recruiting
Study contacts
- Study coordinator: Georgine Lamvu, MD, MPH
- Email: georgine@solapelvictherapy.com
- Phone: 407-461-1189
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Personalized Exercise Recommendations for Chronic Pelvic Pain
This study tests if an AI-powered, personalized exercise plan can help people with chronic pelvic pain see if tailored workouts work better than standard guidance.
-
Pelvic Floor Therapy plus Exercise for Endometriosis-Related Pelvic Pain
This 12-week study tests whether specialized pelvic floor physical therapy plus a structured exercise program helps reduce chronic pelvic pain in women with endometriosis more than a placebo version of pelvic floor therapy plus the same exercise plan.
-
Pelvic Floor Function and Endometriosis-Related Pelvic Pain in Women
This study will look at whether endometriosis-related pelvic pain is linked to pelvic floor muscle strength and related factors in women aged 18–50, comparing them with healthy controls.
-
Educational podcast for people with chronic pelvic pain and endometriosis
This project will test whether giving adults with chronic pelvic pain or endometriosis access to an educational podcast along with their usual care helps improve quality of life, reduce stigma, or increase satisfaction with care compared with usual care alone.
-
How bladder microbes and immune signals affect lower urinary tract health
This project will test whether differences in bladder microbes and immune signals are linked to urinary tract health in adults with and without various urinary conditions.
-
Botulinum toxin injected into the uterine muscle to reduce severe menstrual pain
This trial will test whether a single botulinum toxin injection into the uterine wall via hysteroscopy can reduce severe menstrual cramps in women who did not get relief from first-line hormonal and pain treatments, compared with a placebo injection.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.